<DOC>
	<DOCNO>NCT00901823</DOCNO>
	<brief_summary>This single-center , randomize , open-label , single- multiple-dose , five-treatment , two-period , four-way parallel study compare pharmacokinetics ( PK ) Diazoxide Choline Controlled-Release Tablet ( DCCR ) administer orally feed fasting condition two dose level .</brief_summary>
	<brief_title>Open-Label , Single- Multiple-Dose Pharmacokinetic Study Diazoxide Choline</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Choline</mesh_term>
	<mesh_term>Diazoxide</mesh_term>
	<criteria>Signed informed consent Healthy adult Fasting glucose ≤ 125 mg/dL HbA1C ≤ 6.5 Fasting triglyceride ≥150 mg/dL ≤ 500 mg/dL Known CAD , DM , uncontrolled HTN Pregnancy unable complaint birth control method require</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>